Spots Global Cancer Trial Database for invasive ductal breast carcinoma with predominant intraductal component
Every month we try and update this database with for invasive ductal breast carcinoma with predominant intraductal component cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer | NCT01706432 | Central Nervous... Invasive Ductal... Invasive Ductal... Invasive Lobula... Invasive Lobula... Liver Metastase... Lobular Breast ... Lung Metastases Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Recurrent Breas... Stage IV Breast... Tubular Ductal ... Tumors Metastat... | hyperfractionat... laboratory biom... stereotactic ra... | 18 Years - | University of Chicago | |
Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer | NCT02186470 | Estrogen Recept... Invasive Ductal... Invasive Ductal... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Stage IA Breast... Stage IB Breast... Tubular Ductal ... | accelerated par... intensity-modul... image-guided ra... therapeutic con... | 50 Years - | Ohio State University Comprehensive Cancer Center | |
Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery | NCT00814567 | Breast Cancer | radiation thera... | 50 Years - | Institute of Cancer Research, United Kingdom | |
Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer | NCT00295893 | Breast Cancer | cyclophosphamid... docetaxel doxorubicin hyd... Trastuzumab Carboplatin Paclitaxel | 18 Years - 120 Years | City of Hope Medical Center | |
Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery | NCT00814567 | Breast Cancer | radiation thera... | 50 Years - | Institute of Cancer Research, United Kingdom | |
Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer | NCT02186470 | Estrogen Recept... Invasive Ductal... Invasive Ductal... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Stage IA Breast... Stage IB Breast... Tubular Ductal ... | accelerated par... intensity-modul... image-guided ra... therapeutic con... | 50 Years - | Ohio State University Comprehensive Cancer Center | |
Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer | NCT00182793 | Breast Cancer | trastuzumab carboplatin cyclophosphamid... melphalan thiotepa adjuvant therap... autologous-auto... bone marrow abl... radiation thera... | - 65 Years | City of Hope Medical Center |